Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma (AIR645-CS1)

This study has been completed.
Information provided by:
Altair Therapeutics, Inc. Identifier:
First received: April 11, 2008
Last updated: June 24, 2009
Last verified: June 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)